Anton E. Coleman
Impact in
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
-
- Pharmacological Effects and Toxicity Studies
Papers in
-
- Epilepsy research and treatment 4
- Neurological Complications and Syndromes 1
-
- Alzheimer's disease research and treatments 3
- Diet and metabolism studies 2
- Co-authors
- Andrew G. Herzog (4 shared papers)Frank W. Drislane (3 shared papers)Donald L. Schomer (3 shared papers)Alan R. Jacobs (3 shared papers)Arthur J.L. Cooper (2 shared papers)E. Nieves (1 shared paper)Alan S. Gelbard (1 shared paper)Pavel Klein (2 shared papers)
- Journals
- Neurology (2 papers)Annals of Neurology (2 papers)Biological Psychiatry (1 paper)Journal of Neurochemistry (1 paper)Brain Research (1 paper)
- Partner nations
- United StatesArgentina
In The Last Decade
Anton E. Coleman
12 papers receiving 485 citations
Peers
Comparison fields: 5 of 76
- Psychiatry and Mental health 200
- Pediatrics, Perinatology and Child Health 243
- Clinical Biochemistry 64
- Behavioral Neuroscience 16
- Biochemistry 31
Countries citing papers authored by Anton E. Coleman
This map shows the geographic impact of Anton E. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton E. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton E. Coleman more than expected).
Fields of papers citing papers by Anton E. Coleman
This network shows the impact of papers produced by Anton E. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton E. Coleman. The network helps show where Anton E. Coleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Anton E. Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 112 | |
| 2 | 2003 | 100 | |
| 3 | 1994 | 90 | |
| 4 | 2003 | 60 | |
| 5 | 2000 | 52 | |
| 6 | 1999 | 27 | |
| 7 | 1990 | 23 | |
| 8 | 1989 | 19 | |
| 9 | 1992 | 14 | |
| 10 | 2006 | 8 | |
| 11 | 1987 | 5 | |
| 12 | Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia. | 2020 | 1 |
About Anton E. Coleman
Anton E. Coleman is a scholar working on Psychiatry and Mental health, Physiology, Pediatrics, Perinatology and Child Health, Molecular Biology and Clinical Biochemistry, having authored 12 papers that have together received 511 indexed citations. Recurring topics across this work include Epilepsy research and treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Alzheimer's disease research and treatments (3 papers), Metabolism and Genetic Disorders (3 papers), Mitochondrial Function and Pathology (2 papers), Neonatal and fetal brain pathology (2 papers), Diet and metabolism studies (2 papers) and Neurological Complications and Syndromes (1 paper). The work is most often cited by research in Psychiatry and Mental health (200 citations), Pediatrics, Perinatology and Child Health (243 citations), Clinical Biochemistry (64 citations), Behavioral Neuroscience (16 citations) and Biochemistry (31 citations). Anton E. Coleman has collaborated with scholars based in United States and Argentina. Frequent co-authors include Andrew G. Herzog, Frank W. Drislane, Donald L. Schomer, Alan R. Jacobs, Arthur J.L. Cooper, E. Nieves, Alan S. Gelbard, Pavel Klein, Mark Friedman and Markus J. Seibel. Their work appears in journals such as Neurology, Annals of Neurology, Biological Psychiatry, Journal of Neurochemistry and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.